Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Assessing treatment options for multiple myeloma and managing lenalidomide-refractory disease

Prof Xavier Leleu - Centre Hospitalier Universitaire de Lille, Lille, France
Assessing treatment options for multiple myeloma and managing lenalidomide-refractory disease ( Prof Xavier Leleu - Centre Hospitalier Universitaire de Lille, Lille, France )
14 May 2019

Newly diagnosed multiple myeloma: Laying a solid foundation for improved long-term outcomes

Prof Xavier Leleu - Centre Hospitalier Universitaire de Lille, Lille, France
Newly diagnosed multiple myeloma: Laying a solid foundation for improved long-term outcomes ( Prof Xavier Leleu - Centre Hospitalier Universitaire de Lille, Lille, France )
14 May 2019

Neurological concerns in multiple myeloma

Prof Wolfgang Grisold - Medical University of Vienna, Vienna, Austria
Neurological concerns in multiple myeloma ( Prof Wolfgang Grisold - Medical University of Vienna, Vienna, Austria )
14 May 2019

Filtering through the options: Renal considerations in disease management

Prof Paul Cockwell - University Hospitals Birmingham, Birmingham, UK
Filtering through the options: Renal considerations in disease management ( Prof Paul Cockwell - University Hospitals Birmingham, Birmingham, UK )
14 May 2019

Dr Zsuzsanna Devecseri, EFPIA co-lead for PIONEER, discusses prostate cancer outcomes

Dr Zsuzsanna Devecseri - Head, Global Oncology Medical, Sanofi
Dr Zsuzsanna Devecseri, EFPIA co-lead for PIONEER, discusses prostate cancer outcomes ( Dr Zsuzsanna Devecseri - Head, Global Oncology Medical, Sanofi )
13 May 2019

Dr Thomas Abbott, EFPIA co-lead for PIONEER, discusses data sources and access to data

Dr Thomas Abbott - Head, Real World Evidence at Astellas Pharmaceuticals
Dr Thomas Abbott, EFPIA co-lead for PIONEER, discusses data sources and access to data ( Dr Thomas Abbott - Head, Real World Evidence at Astellas Pharmaceuticals )
13 May 2019

PIONEER research associates from both academic and industry discuss their experience of working together

Claudio Sartini, Katharina Beyer, Eleni Vradi, Dr Lisa Morris, Dr Kostas Dimitropoulos, Dr Peter-Paul Willemse
PIONEER research associates from both academic and industry discuss their experience of working together ( Claudio Sartini, Katharina Beyer, Eleni Vradi, Dr Lisa Morris, Dr Kostas Dimitropoulos, Dr Peter-Paul Willemse )
13 May 2019

Dr Mieke Van Hemelrijck explains the importance of define core outcome sets for prostate cancer

Dr Mieke Van Hemelrijck - Kings College London, Translational Oncology & Urology Research (TOUR)
Dr Mieke Van Hemelrijck explains the importance of define core outcome sets for prostate cancer ( Dr Mieke Van Hemelrijck - Kings College London, Translational Oncology & Urology Research (TOUR) )
13 May 2019

Louise Fullwood explains the legal and ethical issues around data privacy within PIONEER

Louise Fullwood - Legal Director, Pinsent Masons
Louise Fullwood explains the legal and ethical issues around data privacy within PIONEER ( Louise Fullwood - Legal Director, Pinsent Masons )
13 May 2019

Prof James N’Dow, Academic lead for PIONEER, reflects on the first twelve months of the project

Prof James N’Dow - Chairperson, European Association of Urology Guidelines Office
Prof James N’Dow, Academic lead for PIONEER, reflects on the first twelve months of the project ( Prof James N’Dow - Chairperson, European Association of Urology Guidelines Office )
13 May 2019

Pre-operative radiation for pancreatic cancer

Prof Sunil Krishnan - MD Anderson Cancer Center, Houston, USA
Pre-operative radiation for pancreatic cancer ( Prof Sunil Krishnan - MD Anderson Cancer Center, Houston, USA )
9 May 2019

Controversies in the management of prostate cancer

Prof Mach Roach III - University of California, San Francisco, USA
Controversies in the management of prostate cancer ( Prof Mach Roach III - University of California, San Francisco, USA )
9 May 2019